Ph I: phase 1; Ph II: phase 2; AML: Acute Myeloid Leukaemia;
MDS: Myelodysplastic Syndrome; CAR T: Chimeric Antigen Receptor T cell;
ADC: Antibody Drug Conjugate; *: pivotal
FPI: First Patient In; Ph I: phase 1; Ph II: phase 2; AML: Acute Myeloid Leukaemia;
MDS: Myelodysplastic Syndrome; CAR T: Chimeric Antigen Receptor T cell;
ADC: Antibody Drug Conjugate; *: pivotal; DC: drug candidate
© 2024 advesya | All rights reserved
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent or withdrawing consent may negatively impact certain features and functions.